Rising Young Adult Cancer Rates, MaaT Pharma's ALS Therapy Shows Promise, EVE-Vax Transforms Vaccine Design, Exploring New Immunity Research, and more...

(0:10): Study Reveals Alarming Rise in Early-Onset Cancers Among Young Adults, Calls for Urgent Action(2:43): MaaT Pharma's ALS Trial Shows Promise with Safe Microbiome Therapy, Slows Disease Progression(5:13): EVE-Vax Revolutionizes Vaccine Design with Synthetic SARS-CoV-2 Spike Proteins(7:14): Exploring Innate Immunity: New Collection Focuses on Pattern Recognition Receptors and Microbiome Interactions(9:01): Energy Drinks Pose Grave Health Risks for Youth: Urgent Call for RegulationTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Daily Sabah